Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Viking Thera
(NQ:
VKTX
)
76.97
+1.21 (+1.60%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Viking Thera
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Unleashing the Bulls: 3 Top Stocks to Charge Ahead in March
March 13, 2024
This environment presents a compelling opportunity for investors seeking growth. Discover 3 top stocks primed for long-term growth in 2024.
Via
InvestorPlace
Could Viking Therapeutics Challenge Giant Eli Lilly in the Billion-Dollar Weight-Loss Drug Market?
March 13, 2024
Viking aims to enter a market that may be worth $100 billion in a few years.
Via
The Motley Fool
1 Big New Reason to Buy Novo Nordisk Stock Hand Over Fist Right This Instant
March 12, 2024
The pharma giant could have yet another knockout obesity drug on the way.
Via
The Motley Fool
What's Going On With Viking Therapeutics (VKTX) Stock?
March 11, 2024
Viking Therapeutics shares are trading lower by 10.9% Monday afternoon. The stock has experienced marked volatility following a number of key company announcements in February.
Via
Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $900 Today
March 11, 2024
Via
Benzinga
Is Viking Therapeutics Stock a Buy?
March 11, 2024
Its potential is looking increasingly more likely to be realized.
Via
The Motley Fool
Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
February 29, 2024
Via
Benzinga
Missed Out on Eli Lilly and Novo Nordisk? This Could Be the Next Big Weight Loss Stock.
March 09, 2024
Viking Therapeutics has a promising anti-obesity treatment that is generating a lot of interest.
Via
The Motley Fool
3 Stock Winners That Are Up 1,000% or More in 2024
March 08, 2024
Dig deep enough, and find a story hot enough, and you can uncover potential stock winners up 1,000%. Here are three.
Via
InvestorPlace
9 Health Care Stocks Whale Activity In Today's Session
March 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 07, 2024
Via
Benzinga
Why Viking Therapeutics Stock Is Plunging Today
March 07, 2024
The sell-off could present a buying opportunity for aggressive investors willing to bet that the obesity market will be big enough for multiple winners.
Via
The Motley Fool
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 07, 2024
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
Via
Benzinga
Novo Nordisk Jumps On Strong Results For New Weight-Loss Drug
March 07, 2024
Amycretin showed a 13.1% weight loss after 12 weeks in a phase 1 trial.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
March 06, 2024
Via
Benzinga
Is Viking Therapeutics Stock a Better Buy Than Eli Lilly and Novo Nordisk After the Latest Weight-Loss Drug News?
March 06, 2024
A new player in the multibillion-dollar weight-loss drug market could be waiting in the wings.
Via
The Motley Fool
A New Competitor to Wegovy Could Be on the Way. Should Novo Nordisk Be Worried?
March 05, 2024
Here's why I'm not worried.
Via
The Motley Fool
Better Weight Loss Drug Stock: Viking Therapeutics vs. Eli Lilly
March 05, 2024
One is a reigning champion, and the other is a burgeoning contender.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
March 04, 2024
Via
Benzinga
1 Wall Street Analyst Thinks Viking Therapeutics Stock Is Going to $116. Is It a Buy Around $81?
March 04, 2024
It could have even further to rise after its massive run-up.
Via
The Motley Fool
Beyond the "Mag 7": 3 Risk-On Market Forces
March 03, 2024
The biggest bear argument over the past year has been slim leadership in the market, namely concentrated in mega-cap tech stocks such as the “Mag 7.” However, dig deeper, and you will discover there's...
Via
Talk Markets
Better Buy: Eli Lilly vs. Viking Therapeutics
March 03, 2024
These two biotechs could eventually go head to head in a fast-growing market.
Via
The Motley Fool
Missed Out on Novo Nordisk Stock? Buy This 1 Biotech Stock Right Now.
March 03, 2024
The battle for the obesity therapies market is escalating.
Via
The Motley Fool
Why Novo Nordisk Stock Topped the Market Today
March 01, 2024
A favorite of both investors and analysts gets a boost from a bullish move by a pundit.
Via
The Motley Fool
Stock Market Rally At Highs After Big Earnings, Inflation Data: Weekly Review
March 01, 2024
The Nasdaq is on the cusp of setting a record high.
Via
Investor's Business Daily
Topics
Economy
Exposures
Interest Rates
Eli Lilly Stock And The Road To 1,000: Weight-Loss Drugs Could Generate $81 Billion
March 01, 2024
Wall Street isn't properly taking into account Lilly's next-generation drugs, an analyst says.
Via
Investor's Business Daily
2 Stocks That Could Turn $1,000 Into $2,500 in 5 Years
March 01, 2024
It will take a lot, but this goal isn't out of reach for these stocks.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
February 29, 2024
Via
Benzinga
Viking Therapeutics: A Teachable Moment About Investing for the Long Term
February 29, 2024
The biotherapeutics company's weight loss candidate scored a major win this week.
Via
The Motley Fool
Viking Therapeutics Just Soared 120% on Optimism About Its Weight Loss Candidate. Too Late to Buy?
February 29, 2024
Viking stock surged in the triple digits in one trading session.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.